Alsonex Pty. Ltd.

Alsonex Pharmaceuticals is developing a peptide inhibitor of complement factor C5aR1 for the treatment of neurodegenerative diseases including Alzheimer's Disease, Parkinson's Disease and Amyotrophic Lateral Sclerosis.